Resources:

Find resources by:

Sort by:

Date Resource A-Z Random

Resources from the last:

Box size:

Filer text box:

Topic familiarity:

Grid Layout:

Collections that use this topic:

Collection topics:

Adrenal Bone Cardiovascular Diabetes Endocrine-Disrupting Chemicals Endocrine-Related Cancer Metabolism Neuroendocrinology Obesity Reproduction Steroid and Steroidogenesis Thyroid

Metabolism Atherosclerosis

Leptin Ghrelin Adipose Inflammation Thermogenesis Lipolysis Atherosclerosis

Resource not read: Query News

Resource not read: Query Programmes

Resource not read: Query You and Your Hormones

MANAGEMENT OF INHERITED DYSLIPIDAEMIA

SEVERE HYPERTRIGLYCERIDAEMIA AND CHYLOMICRONAEMIA

JOINT POSITION STATEMENT ON BEST PRACTICE RECOMMENDATIONS FOR THE CARE OF WOMEN EXPERIENCING THE MENOPAUSE

SUCCEEDING IN SCIENCE WITH NEURODIVERSITY

Endocrinologist 146 Web

The Endocrinologist Autumn 14 -website.pdf

Endocrinologist 144 Web

Endocrinologist 145 Web

Empagliflozin attenuates the progression of atherosclerosis in APO-E knockout mice

The peculiarities of atherosclerotic coronary arteries lesion in patients with coronary artery disease and type 2 diabetes mellitus

Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human coronary arterial wall and pericoronary adipose tissue in correlation with atherosclerosis

Atrial natriuretic peptide (ANP) attenuates lipid peroxidation in anesthetized atherosclerotic male rabbits by reduction of renin-angotensin-aldosterone system (RAAS) activity

Deficiency in 11β-hydroxysteroid dehydrogenase type 1 reduces systemic inflammation and inflammatory cell infiltration in atherosclerotic lesions of ApoE<sup>−/−</sup> mice

Cardiovascular Autonomic Neuropathy and Early Atherosclerosis in Adolescent Type 1 Diabetic Patient

Plasminogen activator inhibitor 1 and atherosclerosis in diabetes mellitus type 2

Monocytic expression of osteoclast-associated receptor is induced in atherosclerotic mice and regulated by oxidized low-density lipoprotein <em>in vitro</em>

In vitro study of Orexin alpha effects on factors involved in atherosclerosis: a dual role?

Association cystatin C with the presence of carotid atherosclerosis in patients with diabetes type 2 and chronic kidney diseaseassociation cystatin C with the presence of carotid atherosclerosis in patients with diabetes type 2 and chronic kidney disease

Subclinical atherosclerosis is associated with anti-mullerian hormone levels in reproductively women

Follicle stimulating hormone levels and subclinical atherosclerosis in older postmenopausal women

Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

Serum total sialic acid levels in overt and subclinical hypothyroid patients and its relationship with atherosclerotic risk factors

Assessing atherosclerotic risk: carotid intima-media thickness in non-functional adrenal incidentalomas

The impact of gestational weight gain on subclinical atherosclerosis, placental circulation and neonatal complications

Risk factors for Atherosclerosis after Anticancer Treatment in Childhood: The Assessment of Lipid Parameters and Indicators of Susceptibility to Atherosclerosis in a Group of Pediatric Patients after Anticancer Treatment

Vasculature and bone: stages of atherosclerosis come along with changes in gene expression levels of calcification regulators

Evaluation of Subclinical Atherosclerosis by Non-Invasive Radiological Methods and its Relation with Endoglin and Nitric Oxide Levels

Levels of scerostostin in serum and femoral vascular tissue and its relationship with atherosclerosis and cardiovascular mortality in patients with and without type 2 diabetes

Atherosclerosis risk factors before and 90 days after bariatric surgery

Elevated plasma FABP4 (aP2) levels in hypothyroidism: potential implication for accelerated atherosclerosis

Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH

Atherosclerotic cardiovascular risk assessment score in diabetes patients: a retrospective analysis of clinical data

Atherosclerosis in premenopausal diabetic women with or without polycystic ovary syndrome

Association of accelerated coronary atherosclerosis and steroid induced hyperglycemia in craniopharyngeoma operated patient: 15 years follow up patient

Serum vaspin level in patients with diabetes mellitus type 2 as a predictive index of atherosclerosis

10.11. 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

Paraoxonase is reduced in patients with GH deficiency: a risk factor for atherosclerosis?

Dietary patterns as risk factor for arterial stiffness and carotid atherosclerosis in menopause

Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese

Albuminuria and carotid intima-media thickness as surrogate markers of atherosclerosis in asymptomatic patients with type 2 diabetes

Effect of GH receptor antagonist pegvisomant on cardiovascular risk and atherosclerosis in acromegalic patients resistant to somatostatin analogues

The relationship between 25(OH)D levels and markers of atherosclerosis and inflammation in type 2 diabetic patients

High-normal serum uric acid levels in Type 2 diabetes patients with atherosclerotic cardiovascular diseases

Mineral-bone disorder in chronic kidney diseases as early atherosclerosis indicators

What is the earliest predictor of atherosclerosis in normal weight polycystic ovary syndrome; carotid intima media thickness or visceral fat ratio?

Levels of circulating amyloid beta 1-40 are associated with the rate of progression of atherosclerosis in menopause

Deciphering atherosclerosis: unravelling spatial lipid heterogeneity through advanced MALDI-MSI profiling in rabbit aortic and human carotid artery plaques

Plasma visfatin/pre-B-cell colony enhancing factor levels in hypothyroid patients and relationship of these levels with thyroid autoimmunity and atherosclerosis

Signs of accelerated carotid atherosclerosis assessed by MRI in newly diagnosed type 2 diabetes

Atherosclerotic cardiovascular disease and its risk factors in type 2 diabetes in egypt: insights from PACT-MEA study and implications for interventions

The NOS3 and CYBA gene polymorphisms are associated with subclinical atherosclerosis and arterial stiffness in premenopausal women

The usable markers of atherosclerosis measured by Doppler Ultrasound of lower limb artery in treatment- naive hypothyroid females

Atherosclerosis in women of reproductive age with type 2 diabetes mellitus and polycystic ovary syndrome

Gestational diabetes mellitus may associate with atherosclerosis due to high mean platelet volume which is a determined of platelet function

The impact of non-alcoholic fatty liver disease on carotid artery intimamedia thickness as a risk factor for atherosclerosis

Atherosclerosis in patients with prediabetes and type 2 diabetes is associated with more significant microcirculation abnormalities

Risk of diabetes mellitus type 2 and complications associations with atherosclerosis in the population of belarus under 40 years old

Carotid arterial intima-media thickness (IMT), a marker of atherosclerosis, does not differ in patients with acromegaly compared to healthy controls